Phenylalanine hydroxylase: possible involvement in the S-oxidation of S-carboxymethyl-l-cysteine

What is it about?

Activated phenylalanine 4-monooxygenase, phenylalanine hydroxylase (PAH), is known to be involved in the S-oxidation of a number of sulfide compounds. One of these compounds, S-carboxymethyl-L-cysteine (SCMC), is currently used for the treatment of chronic obstructive pulmonary disease and otitis media with effusion as a mucolytic agent, and the S-oxides are the major metabolites found in urine. However, the enzyme catalyzing the S-oxidation of SCMC has yet to be identiWed. Here we report on the role of nonactivated phenylalanine 4-monooxygenase activity in rat liver cytosol in the S-oxidation of SCMC. Linearity of the enzyme assays was seen for both time (0–16min) and cytosolic protein concentration (0.1–0.5mg/ml). The calculated Km and Vmax values for the formation of SCMC (S) S-oxide were 3.92 +/- 0.15mM and 1.10 +/- 0.12nmol SCMC (S) S-oxide formed/mg protein/min, respectively. The calculated Km and Vmax values for the formation of SCMC (R) S-oxide were 9.18 +/- 1.13mM and 0.46 +/- 0.11nmol SCMC (R) S-oxide formed/mg protein/min, respectively. These results indicate that in the female Wistar rat, nonactivated PAH showed a stereospecific preference for the formation of the (S) S-oxide metabolite of SCMC against the (R) S-oxide metabolite of SCMC.

Featured Image

Photo by Thought Catalog on Unsplash

Photo by Thought Catalog on Unsplash

Why is it important?

This paper is the fist report of the involvement of phenylalanine 4 monooxygenase in the S-oxidation of SCMC.